+462.0%
MRNA vs AFRM
-24.5%
+486.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AFRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.2% | +1.0% | +0.9% |
| 7D | -8.2% | -8.5% | +0.3% | -3.9% |
| 30D | +125.6% | -11.4% | +136.9% | +141.1% |
| 3M | +197.1% | +8.2% | +188.8% | +203.5% |
| 6M | +148.5% | +36.6% | +111.9% | +136.6% |
| YTD | +363.3% | -8.7% | +371.9% | +381.8% |
| 1Y | +462.0% | -19.9% | +481.9% | +491.5% |
| All | +462.0% | -24.5% | +486.4% | +491.5% |
Cumulative growth
Daily Returns
Daily percentage return beside AFRM.
Daily Out/Under-Performance
Portfolio return minus AFRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AFRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AFRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling